AU631921B2 - Paf-antagonists - Google Patents

Paf-antagonists

Info

Publication number
AU631921B2
AU631921B2 AU62263/90A AU6226390A AU631921B2 AU 631921 B2 AU631921 B2 AU 631921B2 AU 62263/90 A AU62263/90 A AU 62263/90A AU 6226390 A AU6226390 A AU 6226390A AU 631921 B2 AU631921 B2 AU 631921B2
Authority
AU
Australia
Prior art keywords
paf
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62263/90A
Other versions
AU6226390A (en
Inventor
Jacques Van Meel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU6226390A publication Critical patent/AU6226390A/en
Application granted granted Critical
Publication of AU631921B2 publication Critical patent/AU631921B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AU62263/90A 1989-09-07 1990-09-07 Paf-antagonists Ceased AU631921B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3929763A DE3929763A1 (en) 1989-09-07 1989-09-07 PAF ANTAGONISTS FOR THE MANUFACTURE OF A MEDICAMENT SUITABLE FOR TREATING HEART DISEASES CAUSED BY REDUCED SS RECEPTOR STIMULATION
DE3929763 1989-09-07

Publications (2)

Publication Number Publication Date
AU6226390A AU6226390A (en) 1991-03-14
AU631921B2 true AU631921B2 (en) 1992-12-10

Family

ID=6388841

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62263/90A Ceased AU631921B2 (en) 1989-09-07 1990-09-07 Paf-antagonists

Country Status (11)

Country Link
EP (1) EP0416604A3 (en)
JP (1) JPH03106826A (en)
KR (1) KR910005864A (en)
AU (1) AU631921B2 (en)
CA (1) CA2024630A1 (en)
DD (1) DD299266A5 (en)
DE (1) DE3929763A1 (en)
HU (1) HU206830B (en)
IE (1) IE903237A1 (en)
IL (1) IL95588A0 (en)
ZA (1) ZA907090B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3060287B2 (en) * 1995-10-09 2000-07-10 参天製薬株式会社 Aqueous eye drops containing apaphant as the main drug
KR100426429B1 (en) * 2001-09-05 2004-04-08 김고명 Process for the preparation of the low density polyethylene foaming resin with the heat-resisting
DE102005062417A1 (en) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Hormonal composition, useful in the preparation of agent e.g. against hormone problems and hormone disorder, comprises hormone and prehormone, a ginkgoloid active against alkyl-acyl-glycerophosphocholine, a mineral and a trace element
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
CN104758584A (en) * 2015-03-16 2015-07-08 济南鸿飞生物技术有限公司 Medicament for treating acute heart failure and preparation method thereof
CN115286575A (en) * 2022-06-24 2022-11-04 河南科技大学 Quinolinone seven-eight membered ring derivative and synthesis method and application thereof

Also Published As

Publication number Publication date
HU905810D0 (en) 1991-03-28
AU6226390A (en) 1991-03-14
HUT59827A (en) 1992-07-28
EP0416604A3 (en) 1992-02-05
IL95588A0 (en) 1991-06-30
KR910005864A (en) 1991-04-27
EP0416604A2 (en) 1991-03-13
DD299266A5 (en) 1992-04-09
JPH03106826A (en) 1991-05-07
ZA907090B (en) 1992-05-27
IE903237A1 (en) 1991-03-13
CA2024630A1 (en) 1991-03-08
HU206830B (en) 1993-01-28
DE3929763A1 (en) 1991-03-14

Similar Documents

Publication Publication Date Title
AU5748990A (en) Venoscope
AU5874690A (en) Octreotide-pamoate
AU5064390A (en) Downcomer-tray assembly
AU5348790A (en) Micro-multi-electrode arrangement
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
AU5975590A (en) New substituted 1h-indazole-3-carboxamides
AU623262B2 (en) Hydroxypropylamines
AU6673290A (en) Dipyridodiazepines
AU5922190A (en) Variable chord-forming capotasto
AU631622B2 (en) Snow-vehicle
AU623780B2 (en) Chromanderivate
AU638279B2 (en) Water-actuated novelty
AU5336690A (en) Leg-guard
AU5782590A (en) Thioxotetrazolines
AU6627590A (en) Doll-container
AU6309890A (en) Stabilized leukocyte-interferons
AU6839190A (en) Triazolylsulfonamides
AU5400390A (en) Substituted 1-phenylnaphthalenes
AU631921B2 (en) Paf-antagonists
AU6260690A (en) Further novel alkanophenones
AU5195790A (en) Ligthead assembly
AU6268590A (en) Aminophosphinates
AU5915590A (en) Certain glyoxyl-cyclohexendiones
AU4944090A (en) Cryoelectrosynthesis
AU6217090A (en) Substituted amino-pyridines